Journal article icon

Journal article

Incidence of diabetes following ramipril or rosiglitazone withdrawal

Abstract:

OBJECTIVE - To examine the impact of withdrawing rosiglitazone and ramipril medication on diabetes incidence after closeout of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. RESEARCH DESIGN AND METHODS - The 3,366 DREAM subjects at trial end who had not developed diabetes while taking double-blind study medication were transferred to single-blind placebo for 2 to 3months before undergoing an oral glucose tolerance test. Glycemic status was analyzed...

Expand abstract

Actions


Access Document


Publisher copy:
10.2337/dc10-1567

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, OCDEM, Biomedical Research Centre
Sheridan, PM More by this author
Expand authors...
Journal:
Diabetes Care
Volume:
34
Issue:
6
Pages:
1265-1269
Publication date:
2011-06-05
DOI:
EISSN:
1935-5548
ISSN:
0149-5992
URN:
uuid:654e3bb9-0397-4651-b1c8-cff38ff1ccce
Source identifiers:
179543
Local pid:
pubs:179543
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP